Sygnature Discovery
MARCH 14, 2025
High Throughput Screening Workflow The HTS Workflow is tailored to each of our clients requirements, focusing on developing robust assays with a flexible approach, especially in selecting hits to balance false positives and negatives. The process begins with assay development or transfer.
Drug Target Review
NOVEMBER 1, 2023
We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. We often screen using a biochemical assay, but we can conduct cell-based screening as well. We need to build the assays that we need for compound screening.
Expert insights. Personalized for you.
Let's personalize your content